BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 3276531)

  • 1. The role of oestrogens and progestagens in the epidemiology and prevention of breast cancer.
    Key TJ; Pike MC
    Eur J Cancer Clin Oncol; 1988 Jan; 24(1):29-43. PubMed ID: 3276531
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiologic aspects of exogenous progestagens in relation to their role in pathogenesis of human breast cancer.
    van Leeuwen FE
    Acta Endocrinol (Copenh); 1991; 125 Suppl 1():13-26. PubMed ID: 1801500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dose-effect relationship between 'unopposed' oestrogens and endometrial mitotic rate: its central role in explaining and predicting endometrial cancer risk.
    Key TJ; Pike MC
    Br J Cancer; 1988 Feb; 57(2):205-12. PubMed ID: 3358913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endometrial cancer and hormone-replacement therapy in the Million Women Study.
    Beral V; Bull D; Reeves G;
    Lancet; 2005 Apr 30-May 6; 365(9470):1543-51. PubMed ID: 15866308
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of endogenous and exogenous hormones on breast cancer: epidemiology.
    Vessey MP
    Verh Dtsch Ges Pathol; 1997; 81():493-501. PubMed ID: 9474890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogens, progestogens, normal breast cell proliferation, and breast cancer risk.
    Pike MC; Spicer DV; Dahmoush L; Press MF
    Epidemiol Rev; 1993; 15(1):17-35. PubMed ID: 8405201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence.
    Collaborative Group on Hormonal Factors in Breast Cancer
    Lancet; 2019 Sep; 394(10204):1159-1168. PubMed ID: 31474332
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of hormone replacement therapy and route of administration on selected cardiovascular risk factors in post-menopausal women.
    Seed M; Sands RH; McLaren M; Kirk G; Darko D
    Fam Pract; 2000 Dec; 17(6):497-507. PubMed ID: 11120722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Menstrual cycle and exposure to oestrogens unopposed by progesterone: relevance to studies on breast cancer incidence.
    Metcalf MG; Mackenzie JA
    J Endocrinol; 1985 Jan; 104(1):137-41. PubMed ID: 3968497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biology of female sex hormone action in relation to contraceptive agents and neoplasia.
    King RJ
    Contraception; 1991 Jun; 43(6):527-42. PubMed ID: 1651204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer and hormone-replacement therapy in the Million Women Study.
    Beral V;
    Lancet; 2003 Aug; 362(9382):419-27. PubMed ID: 12927427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hormone replacement therapy and cancer.
    Gynecol Endocrinol; 2001 Dec; 15(6):453-65. PubMed ID: 11826770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Breast-cancer risk following long-term oestrogen- and oestrogen-progestin-replacement therapy.
    Magnusson C; Baron JA; Correia N; Bergström R; Adami HO; Persson I
    Int J Cancer; 1999 May; 81(3):339-44. PubMed ID: 10209946
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Controversial issues in climacteric medicine II. Hormone replacement therapy and cancer. International Menopause Society Expert Workshop. 9-12 June 2001, Opera del Duomo, Pisa, Italy.
    Genazzani AR; Gadducci A; Gambacciani M
    Climacteric; 2001 Sep; 4(3):181-93. PubMed ID: 11588941
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of sex steroids on proliferation in normal mammary tissue.
    Söderqvist G
    Ann Med; 1998 Dec; 30(6):511-24. PubMed ID: 9920352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The present state of research on the relationship of oral contraceptives to breast cancer].
    Pike MC
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):329-38. PubMed ID: 12280203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormones and cancer in humans.
    Key TJ
    Mutat Res; 1995 Dec; 333(1-2):59-67. PubMed ID: 8538637
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevention of breast cancer through reduced ovarian steroid exposure.
    Spicer DV; Pike MC
    Acta Oncol; 1992; 31(2):167-74. PubMed ID: 1622631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hormone replacement therapy and breast cancer.
    Jacobs HS
    Endocr Relat Cancer; 2000 Mar; 7(1):53-61. PubMed ID: 10808196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monitoring ovarian cycle and pregnancy in the giant anteater (Myrmecophaga tridactyla) by faecal progestagen and oestrogen analysis.
    Patzl M; Schwarzenberger F; Osmann C; Bamberg E; Bartmann W
    Anim Reprod Sci; 1998 Oct; 53(1-4):209-19. PubMed ID: 9835377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.